PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
8.60%
Positive revenue growth while TSM is negative. John Neff might see a notable competitive edge here.
11.73%
Positive gross profit growth while TSM is negative. John Neff would see a clear operational edge over the competitor.
57.04%
Positive EBIT growth while TSM is negative. John Neff might see a substantial edge in operational management.
57.04%
Positive operating income growth while TSM is negative. John Neff might view this as a competitive edge in operations.
50.26%
Positive net income growth while TSM is negative. John Neff might see a big relative performance advantage.
37.50%
Positive EPS growth while TSM is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
46.67%
Positive diluted EPS growth while TSM is negative. John Neff might view this as a strong relative advantage in controlling dilution.
9.35%
Slight or no buybacks while TSM is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
1.42%
Diluted share count expanding well above TSM's 0.05%. Michael Burry would fear significant dilution to existing owners' stakes.
No Data
No Data available this quarter, please select a different quarter.
168.00%
OCF growth above 1.5x TSM's 14.94%. David Dodd would confirm a clear edge in underlying cash generation.
185.90%
FCF growth above 1.5x TSM's 70.39%. David Dodd would verify if the firm’s strategic investments yield superior returns.
298.63%
Positive 10Y revenue/share CAGR while TSM is negative. John Neff might see a distinct advantage in product or market expansion over the competitor.
152.62%
Positive 5Y CAGR while TSM is negative. John Neff might see an underappreciated edge for the firm vs. the competitor.
21.74%
Positive 3Y CAGR while TSM is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
3335.25%
OCF/share CAGR of 3335.25% while TSM is zero. Bruce Berkowitz might see a slight advantage that could compound over time.
1162.24%
OCF/share CAGR of 1162.24% while TSM is zero. Bruce Berkowitz would see if modest momentum can translate into a bigger competitive lead.
63.35%
3Y OCF/share CAGR 1.25-1.5x TSM's 42.91%. Bruce Berkowitz might see if strategic cost controls or product mix drove recent gains.
442.52%
Net income/share CAGR 1.25-1.5x TSM's 350.57%. Bruce Berkowitz might see more effective use of capital or consistently better margins over time.
174.65%
Below 50% of TSM's 568.72%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
73.45%
3Y net income/share CAGR 1.25-1.5x TSM's 64.85%. Bruce Berkowitz might see new markets, M&A, or better cost discipline driving the difference.
845.10%
10Y equity/share CAGR above 1.5x TSM's 433.00%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
212.61%
5Y equity/share CAGR above 1.5x TSM's 72.66%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
40.83%
3Y equity/share CAGR at 75-90% of TSM's 52.09%. Bill Ackman pushes for margin or operational changes to match the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-9.54%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
-10.55%
Inventory is declining while TSM stands at 16.70%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
6.08%
Similar asset growth to TSM's 6.63%. Walter Schloss finds parallel expansions or investment rates.
-1.21%
We have a declining book value while TSM shows 6.18%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
5.12%
R&D dropping or stable vs. TSM's 23.38%. David Dodd sees near-term margin benefits if the product pipeline is already strong.
-8.02%
We cut SG&A while TSM invests at 153.09%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.